查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1871991

經導管主動脈瓣置換術（TAVI）用腦栓塞保護裝置：全球市場佔有率和排名、總收入和需求預測（2025-2031 年）

Cerebral Embolic Protection Devices for TAVI - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 95 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年，全球用於經導管主動脈瓣置換術 (TAVI) 的腦栓塞保護裝置的市場規模估計為 1.04 億美元，預計到 2031 年將達到 3.84 億美元，在預測期（2025-2031 年）內，複合年成長率為 19.9%。

本報告對近期經導管主動脈瓣置換術 (TAVR) 腦栓塞保護裝置的關稅調整和國際戰略應對措施進行了全面評估，包括跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組。

經導管主動脈瓣置換術（TAVI），也稱為經導管主動脈瓣置換術（TAVR），用於治療主動脈瓣狹窄（AS）。對於不適合或手術風險極高的重度主動脈瓣狹窄患者，經導管主動脈瓣置換術是首選治療方法。然而，TAVI 的益處會被中風的發生所抵消，中風會導致嚴重的殘疾，並增加死亡率和生活品質的早期下降。儘管 TAVI 技術不斷進步，但中風仍然是一個重要的併發症，並與嚴重的不良後果相關。大多數中風發生在手術全期術後的急性期，此時腦栓塞較為常見。腦栓塞保護裝置（CEPD）的研發旨在最大限度地降低 TAVI 術中缺血性中風的風險。

經導管主動脈瓣置換術（TAVI）是一種微創治療方法，適用於高風險老年患者和有手術風險的患者。近年來，TAVI已成為心血管領域的重大突破。 TAVI技術不僅顯著提高了瓣膜置換治療的安全性和有效性，也顯著改善了患者的生活品質。然而，TAVI手術仍有一定的風險，尤其是腦栓塞的風險，這仍然是臨床治療中面臨的持續挑戰。為了有效降低TAVI手術過程中可能發生的腦栓塞事件，腦栓塞保護裝置（CEPD）應運而生，成為確保TAVI治療安全性和病人預後的重要技術手段。

隨著經導管主動脈瓣置換術（TAVI）技術的日益普及和廣泛接受，市場對腦栓塞保護裝置的需求也不斷成長。在TAVI手術過程中，尤其是在經股動脈植入瓣膜時，瓣膜植入器或導管的操作可能導致微小血栓脫落，進而引發腦栓塞。此類腦栓塞事件可導致中風和其他神經系統併發症，影響患者預後。為了有效預防這種風險，腦栓塞保護裝置（CEPD）應運而生，並迅速成為TAVI手術的標準配備。

腦

在全球範圍內，經導管主動脈瓣置換術（TAVI）技術及相關保護裝置的應用在歐美市場起步較早，且市場接受度較高。尤其是在美國，TAVI手術中常規使用腦栓塞保護裝置的比例正在上升。在中國及其他亞洲地區，TAVI技術的普及也帶動了對腦栓塞保護裝置的市場需求。儘管與歐美市場相比，亞洲市場仍處於起步階段，但醫療技術和健康理念的不斷進步意味著其市場潛力巨大。

Venus Meditech（Keystone Heart）是全球最大的經導管主動脈瓣置換術（TAVI）腦栓塞保護裝置製造商，市佔率超過90%。從區域來看，TAVI腦栓塞保護裝置市場目前僅存在於歐洲和美國，其中北美約佔55%的市佔率。按動脈覆蓋範圍分類，非全動脈覆蓋部分佔據了超過90%的市場。按應用領域分類，醫院應用約佔全球市場佔有率的80%。

本報告旨在按地區/國家、類型和應用對全球經導管主動脈瓣置換術 (TAVI) 腦栓塞保護裝置市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

本報告以銷售量（單位）和收入（百萬美元）為指標，對經導管主動脈瓣置換術（TAVI）腦栓塞保護裝置的市場規模、估計值和預測進行了闡述，以2024年為基準年，並涵蓋了2020年至2031年的歷史數據和預測數據。透過定量和定性分析，我們幫助讀者制定TAVI腦栓塞保護裝置的業務和成長策略，評估市場競爭情況，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • Boston Scientific（Claret Medical）
  • Venus Medtech（Keystone Heart）
  • Transverse Medical
  • Emboline
  • Protembis GmbH
  • Filterlex Medical

按類型分類的細分市場

  • 全動脈應用
  • 非全動脈應用

應用領域

  • 醫院
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Cerebral Embolic Protection Devices for TAVI was estimated to be worth US$ 104 million in 2024 and is forecast to a readjusted size of US$ 384 million by 2031 with a CAGR of 19.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Cerebral Embolic Protection Devices for TAVI cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.

TAVI (transcatheter aortic valve implantation), as a minimally invasive treatment for high-risk elderly patients or patients with surgical risks, has become one of the important breakthroughs in the cardiovascular field in recent years. TAVI technology has not only significantly improved the safety and effectiveness of valve replacement therapy, but also greatly improved the quality of life of patients. However, there are certain risks in the TAVI operation, especially the risk of cerebral embolism, which has always been a challenge in clinical treatment. In order to effectively reduce the cerebral embolic events that may occur during TAVI surgery, cerebral embolic protection devices (CEPDs) came into being and became an important technical means to ensure the safety of TAVI treatment and patient prognosis.

At present, with the widespread application and acceptance of TAVI technology, the market demand for cerebral embolic protection devices is also growing. During TAVI surgery, especially when valve implantation is performed through the femoral artery, tiny blood clots may fall off due to the operation of the valve implanter and catheter, thereby causing cerebral embolism. This cerebral embolic event can cause stroke or other neurological complications, affecting the patient's prognosis. In order to effectively prevent this risk, CEPDs came into being and quickly became one of the standard configurations in TAVI surgery.

Brain

Globally, the European and American markets started early in the application of TAVI technology and related protection devices, and the market acceptance is high. Especially in the United States and Europe, more and more TAVI surgeries are beginning to routinely use cerebral embolic protection devices. In China and other Asian regions, with the gradual popularization of TAVI technology, the market demand for cerebral embolic protection devices is also rising. Although it is still in its infancy compared to the European and American markets, with the continuous advancement of medical technology and health concepts, the market potential is huge.

Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.

This report aims to provide a comprehensive presentation of the global market for Cerebral Embolic Protection Devices for TAVI, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cerebral Embolic Protection Devices for TAVI by region & country, by Type, and by Application.

The Cerebral Embolic Protection Devices for TAVI market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cerebral Embolic Protection Devices for TAVI.

Market Segmentation

By Company

  • Boston Scientific (Claret Medical)
  • Venus Medtech (Keystone Heart)
  • Transverse Medical
  • Emboline
  • Protembis GmbH
  • Filterlex Medical

Segment by Type

  • Total Artery Coverage
  • Non-total Artery Coverage

Segment by Application

  • Hopsital
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Cerebral Embolic Protection Devices for TAVI manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Cerebral Embolic Protection Devices for TAVI in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Cerebral Embolic Protection Devices for TAVI in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Cerebral Embolic Protection Devices for TAVI Product Introduction
  • 1.2 Global Cerebral Embolic Protection Devices for TAVI Market Size Forecast
    • 1.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value (2020-2031)
    • 1.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume (2020-2031)
    • 1.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Price (2020-2031)
  • 1.3 Cerebral Embolic Protection Devices for TAVI Market Trends & Drivers
    • 1.3.1 Cerebral Embolic Protection Devices for TAVI Industry Trends
    • 1.3.2 Cerebral Embolic Protection Devices for TAVI Market Drivers & Opportunity
    • 1.3.3 Cerebral Embolic Protection Devices for TAVI Market Challenges
    • 1.3.4 Cerebral Embolic Protection Devices for TAVI Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Cerebral Embolic Protection Devices for TAVI Players Revenue Ranking (2024)
  • 2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Company (2020-2025)
  • 2.3 Global Cerebral Embolic Protection Devices for TAVI Players Sales Volume Ranking (2024)
  • 2.4 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Company Players (2020-2025)
  • 2.5 Global Cerebral Embolic Protection Devices for TAVI Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Cerebral Embolic Protection Devices for TAVI Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Cerebral Embolic Protection Devices for TAVI Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Cerebral Embolic Protection Devices for TAVI
  • 2.9 Cerebral Embolic Protection Devices for TAVI Market Competitive Analysis
    • 2.9.1 Cerebral Embolic Protection Devices for TAVI Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Cerebral Embolic Protection Devices for TAVI Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebral Embolic Protection Devices for TAVI as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Total Artery Coverage
    • 3.1.2 Non-total Artery Coverage
  • 3.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type
    • 3.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Type (2020-2031)
    • 3.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type
    • 3.3.1 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Cerebral Embolic Protection Devices for TAVI Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hopsital
    • 4.1.2 Others
  • 4.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application
    • 4.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Application (2020-2031)
    • 4.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application
    • 4.3.1 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Cerebral Embolic Protection Devices for TAVI Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region
    • 5.1.1 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2020-2025)
    • 5.1.3 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2026-2031)
    • 5.1.4 Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (%), (2020-2031)
  • 5.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region
    • 5.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2020-2025)
    • 5.2.3 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2026-2031)
    • 5.2.4 Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Cerebral Embolic Protection Devices for TAVI Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 5.4.2 North America Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 5.5.2 Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 5.7.2 South America Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.3.2 United States Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.4.2 Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.5.2 China Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.6.2 Japan Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.7.2 South Korea Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Cerebral Embolic Protection Devices for TAVI Sales Value, 2020-2031
    • 6.9.2 India Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Cerebral Embolic Protection Devices for TAVI Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Boston Scientific (Claret Medical)
    • 7.1.1 Boston Scientific (Claret Medical) Company Information
    • 7.1.2 Boston Scientific (Claret Medical) Introduction and Business Overview
    • 7.1.3 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.1.5 Boston Scientific (Claret Medical) Recent Development
  • 7.2 Venus Medtech (Keystone Heart)
    • 7.2.1 Venus Medtech (Keystone Heart) Company Information
    • 7.2.2 Venus Medtech (Keystone Heart) Introduction and Business Overview
    • 7.2.3 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.2.5 Venus Medtech (Keystone Heart) Recent Development
  • 7.3 Transverse Medical
    • 7.3.1 Transverse Medical Company Information
    • 7.3.2 Transverse Medical Introduction and Business Overview
    • 7.3.3 Transverse Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Transverse Medical Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.3.5 Transverse Medical Recent Development
  • 7.4 Emboline
    • 7.4.1 Emboline Company Information
    • 7.4.2 Emboline Introduction and Business Overview
    • 7.4.3 Emboline Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Emboline Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.4.5 Emboline Recent Development
  • 7.5 Protembis GmbH
    • 7.5.1 Protembis GmbH Company Information
    • 7.5.2 Protembis GmbH Introduction and Business Overview
    • 7.5.3 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.5.5 Protembis GmbH Recent Development
  • 7.6 Filterlex Medical
    • 7.6.1 Filterlex Medical Company Information
    • 7.6.2 Filterlex Medical Introduction and Business Overview
    • 7.6.3 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Product Offerings
    • 7.6.5 Filterlex Medical Recent Development

8 Industry Chain Analysis

  • 8.1 Cerebral Embolic Protection Devices for TAVI Industrial Chain
  • 8.2 Cerebral Embolic Protection Devices for TAVI Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Cerebral Embolic Protection Devices for TAVI Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Cerebral Embolic Protection Devices for TAVI Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Cerebral Embolic Protection Devices for TAVI Market Trends
  • Table 2. Cerebral Embolic Protection Devices for TAVI Market Drivers & Opportunity
  • Table 3. Cerebral Embolic Protection Devices for TAVI Market Challenges
  • Table 4. Cerebral Embolic Protection Devices for TAVI Market Restraints
  • Table 5. Global Cerebral Embolic Protection Devices for TAVI Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Cerebral Embolic Protection Devices for TAVI Revenue Market Share by Company (2020-2025)
  • Table 7. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Company (2020-2025) & (Units)
  • Table 8. Global Cerebral Embolic Protection Devices for TAVI Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Cerebral Embolic Protection Devices for TAVI Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Cerebral Embolic Protection Devices for TAVI Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Cerebral Embolic Protection Devices for TAVI Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Cerebral Embolic Protection Devices for TAVI
  • Table 13. Global Cerebral Embolic Protection Devices for TAVI Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebral Embolic Protection Devices for TAVI as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
  • Table 22. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type (2020-2025) & (Units)
  • Table 23. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type (2026-2031) & (Units)
  • Table 24. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Cerebral Embolic Protection Devices for TAVI Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Cerebral Embolic Protection Devices for TAVI Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
  • Table 34. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application (2020-2025) & (Units)
  • Table 35. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application (2026-2031) & (Units)
  • Table 36. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Cerebral Embolic Protection Devices for TAVI Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Cerebral Embolic Protection Devices for TAVI Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Cerebral Embolic Protection Devices for TAVI Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (Units): 2020 VS 2024 VS 2031
  • Table 46. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2020-2025) & (Units)
  • Table 47. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2026-2031) & (Units)
  • Table 48. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Cerebral Embolic Protection Devices for TAVI Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Cerebral Embolic Protection Devices for TAVI Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Volume, (2020-2025) & (Units)
  • Table 56. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Volume, (2026-2031) & (Units)
  • Table 57. Boston Scientific (Claret Medical) Company Information
  • Table 58. Boston Scientific (Claret Medical) Introduction and Business Overview
  • Table 59. Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 61. Boston Scientific (Claret Medical) Recent Development
  • Table 62. Venus Medtech (Keystone Heart) Company Information
  • Table 63. Venus Medtech (Keystone Heart) Introduction and Business Overview
  • Table 64. Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 66. Venus Medtech (Keystone Heart) Recent Development
  • Table 67. Transverse Medical Company Information
  • Table 68. Transverse Medical Introduction and Business Overview
  • Table 69. Transverse Medical Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Transverse Medical Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 71. Transverse Medical Recent Development
  • Table 72. Emboline Company Information
  • Table 73. Emboline Introduction and Business Overview
  • Table 74. Emboline Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Emboline Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 76. Emboline Recent Development
  • Table 77. Protembis GmbH Company Information
  • Table 78. Protembis GmbH Introduction and Business Overview
  • Table 79. Protembis GmbH Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Protembis GmbH Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 81. Protembis GmbH Recent Development
  • Table 82. Filterlex Medical Company Information
  • Table 83. Filterlex Medical Introduction and Business Overview
  • Table 84. Filterlex Medical Cerebral Embolic Protection Devices for TAVI Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Filterlex Medical Cerebral Embolic Protection Devices for TAVI Product Offerings
  • Table 86. Filterlex Medical Recent Development
  • Table 87. Key Raw Materials Lists
  • Table 88. Raw Materials Key Suppliers Lists
  • Table 89. Cerebral Embolic Protection Devices for TAVI Downstream Customers
  • Table 90. Cerebral Embolic Protection Devices for TAVI Distributors List
  • Table 91. Research Programs/Design for This Report
  • Table 92. Key Data Information from Secondary Sources
  • Table 93. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Cerebral Embolic Protection Devices for TAVI Product Picture
  • Figure 2. Global Cerebral Embolic Protection Devices for TAVI Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Cerebral Embolic Protection Devices for TAVI Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Cerebral Embolic Protection Devices for TAVI Sales Volume (2020-2031) & (Units)
  • Figure 5. Global Cerebral Embolic Protection Devices for TAVI Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Cerebral Embolic Protection Devices for TAVI Report Years Considered
  • Figure 7. Global Cerebral Embolic Protection Devices for TAVI Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Cerebral Embolic Protection Devices for TAVI Players Sales Volume Ranking (2024) & (Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cerebral Embolic Protection Devices for TAVI Revenue in 2024
  • Figure 10. Cerebral Embolic Protection Devices for TAVI Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Total Artery Coverage Picture
  • Figure 12. Non-total Artery Coverage Picture
  • Figure 13. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Cerebral Embolic Protection Devices for TAVI Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
  • Figure 16. Global Cerebral Embolic Protection Devices for TAVI Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Cerebral Embolic Protection Devices for TAVI Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Hopsital
  • Figure 19. Product Picture of Others
  • Figure 20. Global Cerebral Embolic Protection Devices for TAVI Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 21. Global Cerebral Embolic Protection Devices for TAVI Sales Value Market Share by Application, 2024 & 2031
  • Figure 22. Global Cerebral Embolic Protection Devices for TAVI Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
  • Figure 23. Global Cerebral Embolic Protection Devices for TAVI Sales Volume Market Share by Application, 2024 & 2031
  • Figure 24. Global Cerebral Embolic Protection Devices for TAVI Price by Application (2020-2031) & (US$/Unit)
  • Figure 25. North America Cerebral Embolic Protection Devices for TAVI Sales Value (2020-2031) & (US$ Million)
  • Figure 26. North America Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Europe Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales Value by Region (%), 2024 VS 2031
  • Figure 31. South America Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. South America Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • Figure 33. Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Value (%), (2020-2031)
  • Figure 36. Key Countries/Regions Cerebral Embolic Protection Devices for TAVI Sales Volume (%), (2020-2031)
  • Figure 37. United States Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. United States Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 39. United States Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Europe Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Europe Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 43. China Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. China Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 45. China Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Japan Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Japan Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Japan Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 49. South Korea Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. South Korea Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 51. South Korea Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 53. Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 54. Southeast Asia Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 55. India Cerebral Embolic Protection Devices for TAVI Sales Value, (2020-2031) & (US$ Million)
  • Figure 56. India Cerebral Embolic Protection Devices for TAVI Sales Value by Type (%), 2024 VS 2031
  • Figure 57. India Cerebral Embolic Protection Devices for TAVI Sales Value by Application (%), 2024 VS 2031
  • Figure 58. Cerebral Embolic Protection Devices for TAVI Industrial Chain
  • Figure 59. Cerebral Embolic Protection Devices for TAVI Manufacturing Cost Structure
  • Figure 60. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 61. Bottom-up and Top-down Approaches for This Report
  • Figure 62. Data Triangulation
  • Figure 63. Key Executives Interviewed